Could a high-fat diet rich in unsaturated fatty acids impair the cardiovascular system?

Canadian Journal of Cardiology

Volumn 26, Issue 10, 2010, Pages 542-548

  Medei, Emiliano ^a   Lima Leopoldo, Ana Paula ^b   Pereira Junior, Pedro Paulo ^a   Leopoldo, André Soares ^c   Campos, Dijon Henrique Salomé ^c   Raimundo, Juliana Montani ^a   Sudo, Roberto Takashi ^a   Zapata Sudo, Gisele ^a   Bruder Nascimento, Thiago ^c   Cordellini, Sandra ^c   Nascimento, José Hamilton Matheus ^a   Cicogna, Antonio Carlos ^c  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^c SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Cardiovascular; High fat diet; Obesity; Unsaturated fatty acid

Indexed keywords

ACETYLCHOLINE; FAT; GLUCOSE; NORADRENALIN; PHENYLEPHRINE; PRAZOSIN; UNSATURATED FATTY ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTERY CONSTRICTION; ARTICLE; BODY WEIGHT; CALORIC INTAKE; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RESPONSE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DRUG RESPONSE; DRUG SENSITIVITY; ELECTROCARDIOGRAM; FATTY ACID BLOOD LEVEL; FEEDING; GLUCOSE BLOOD LEVEL; HEART RATE VARIABILITY; HEART WEIGHT; IN VIVO STUDY; LIPID DIET; MALE; NONHUMAN; RAT; SPECTROSCOPY; SYSTOLIC BLOOD PRESSURE; THORACIC AORTA; VASCULAR RING;

EID: 78650202697     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0828-282X(10)70469-4     Document Type: Article

References (51)

1. Curb JD, Wergowske G, Dobbs JC, Abbott RD, Huang B. Serum lipid effects of a high-monounsaturated fat diet based on macadamia nuts. Arch Intern Med 2000;160:1154-8.
2. AHA. Heart disease and stroke statistics: 2008 update. 〈http://www.americanheart.org/presenter.jhtml?identifier1/41928〉 (Accessed October 2008).
3. Matthan NR, Dillard A, Lecker JL, Ip B, Lichtenstein AH. Effects of dietary palmitoleic acid on plasma lipoprotein profile and aortic cholesterol accumulation are similar to those of other unsaturated fatty acids in the F1B golden Syrian hamster. J Nutr 2009;139:215-21.
4. Lopaschuck GD, Folmes CD, Stanley WC. Cardiac energy metabolism in obesity. Circ Res 2007;101:335-47.
5. O'Brien PE, Dixon JB. The extent of the problem of obesity. Am J Surg 2002;184(6B):4S-8S.
6. Stein CJ, Colditz GA. The epidemic of obesity. J Clin Endocrinol Metab 2004;89:2522-5.
7. Gordon T, Kannel WB. Obesity and cardiovascular disease: The Framingham Study. Clin Endocrinol Metab 1976;5:367-75.
8. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: A 26-year follow-up of participants in the Framingham Study. Circulation 1983;67:968-77.
9. Artham SM, Lavie CJ, Patel HM, Ventura HO. Impact of obesity on the risk of heart failure and its prognosis. J Cardiometab Syndr 2008;3:155-61. (Rev)
10. Poirier P, Giles TD, Bray GA, et al. American Heart Association; Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Obesity and cardiovascular disease: Pathophysiology, evaluation, and effect of weight loss. Circulation 2006;113:898-918. (Rev)
11. Carroll JF, Dwyer TM, Grady AW, et al. Hypertension, cardiac hypertrophy, and neurohumoral activity in a new animal model of obesity. Am J Physiol 1996;271:H373-8.
12. Levin BE, Dunn-Meynell AA, Balkan B, Keesey RE. Selective breeding for diet-induced obesity and resistance in Sprague-Dawley rats. Am J Physiol 1997;273:R725-30.
13. Swinburn B, Egger G. Preventive strategies against weight gain and obesity. Obes Rev 2002;3:289-301.
14. Frank S, Colliver JA, Frank A. The electrocardiogram in obesity: Statistical analysis of 1,029 patients. J Am Coll Cardiol 1986;7:295-9.
15. Fraley MA, Birchem JA, Senkottaiyan N, Alpert MA. Obesity and the electrocardiogram. Obes Rev 2005;6:275-81.
16. Esposito K, Nicoletti G, Marzano S, et al. Autonomic dysfunction associates with prolongation of QT intervals and blunted night BP in obese women with visceral obesity. J Endocrinol Invest 2002;25:RC32-5.
17. Papaioannou A, Michaloudis D, Fraidakis O, et al. Effects of weight loss in QT interval in morbidly obese patients. Obes Surg 2003;13:869-73.
18. el-Gamal A, Gallagher D, Nawras A, et al. Effects of obesity on QT, RR, and QTc intervals. Am J Cardiol 1995;75:956-9.
19. Vlay SC, Mallis GI, Brown EJ, Cohn PF. Documented sudden cardiac death in prolonged QT syndrome. Arch Intern Med 1984;144:833-5.
20. Moss AJ. Measurement of the QT interval and the risk associated with QTc interval prolongation: A review. Am J Cardiol 1993;72:23B-25B.
21. Corbi GM, Carbone S, Ziccardi P, et al. FFAs and QT intervals in obese women with visceral adiposity: Effects of sustained weight loss over 1 year. J Clin Endocrinol Metab 2002;87:2080-3.
22. Naderali EK, Pickavance LC, Wilding JPH, Williams G. Diet-induced endothelial dysfunction in the rat is independent of the degree of increase in total body weight. Clin Sci 2001;100:635-41.
23. Mundy AL, Haas E, Bhattacharya I, et al. Fat intake modifies vascular responsiveness and receptor expression of vasoconstrictors: Implications for diet-induced obesity. Cardiovasc Res 2007;73:368-75.
24. Smith AD, Brands MW, Wang MH, Dorrance AM. Obesity-induced hypertension develops in young rats independently of the renin-angiotensin-aldosterone system. Exp Biol Med 2006;231:282-7.
25. Seiler C, Hess OM, Buechi M, Suter TM, Kayenbuehl HP. Influence of serum cholesterol and other coronary risk factors on vasomotion of angiographically normal coronary arteries. Circulation 1993;88:2139-48.
26. Mietus-Snyder M, Malloy MJ. Endothelial dysfunction occurs in children with two genetic hyperlipidemias: Improvement with antioxidant vitamin therapy. J Pediatr 1998;133:35-40.
27. Vogel RA, Corretti MC, Plotnick GD. Effect of a single high-fat meal on endothelial function in healthy subjects. Am J Cardiol 1997;79:350-4.
28. Lauterio TJ, Bond JP, Ulman EA. Development and characterization of a purified diet to identify obesity-susceptible and resistant rat populations. J Nutr 1994;124:2172-8.
29. Woods SC, Seeley RJ, Rushing PA, D'Alessio DA, Tso P. A controlled high-fat diet induces an obese syndrome in rats. J Nutr 2003;133:1081-7.
30. Brufau G, Canela MA, Rafecas M. A high-saturated fat diet enriched with phytosterol and pectin affects the fatty acid profile in guinea pigs. Lipids 2006;41:159-68.
31. Boustany CM, Bharadwaj K, Daugherty A, Brown DR, Randall DC, Cassis LA. Activation of the systemic and adipose renin-angiotensin system in rats with diet-induced obesity and hypertension. Am J Physiol Regul Integr Comp Physiol 2004;287:R943-9.
32. Pfeffer JM, Pfeffer MA, Frohlich ED. Validity of an indirect tail-cuff method for determining systolic arterial pressure in unanesthetized normotensive and spontaneously hypertensive rats. J Lab Clin Med 1971;78:957-62.
33. Carvalho-Filho MA, Ueno M, Hirabara SM, et al. S-nitrosation of the insulin receptor, insulin receptor substrate 1, and protein kinase B/Akt: A novel mechanism of insulin resistance. Diabetes 2005;54:959-67.
34. Nascimento AF, Sugizaki MM, Leopoldo AS, et al. Misclassification probability as obese or lean in hypercaloric and normocaloric diet. Biol Res 2009;41:253-9.
35. Okere IC, Chandler MP, McElfresh TA, et al. Differential effects of saturated and unsaturated fatty acid diets on cardiomyocyte apoptosis, adipose distribution, and serum leptin. Am J Physiol Heart Circ Physiol 2006;291:H38-R44.
36. Rousseau D, Héliès-Toussaint C, Moreau D, Raederstorff D, Grynberg A. Dietary n-3 PUFAs affect the blood pressure rise and cardiac impairments in a hyperinsulinemia rat model in vivo. Am J Physiol Heart Circ Physiol 2003;285:H1294-302.
37. Lombardi F, Terranova P. Anti-arrhythmic properties of N-3 poly-unsaturated fatty acids (n-3 PUFA). Curr Med Chem 2007;14:2070-80. (Rev)
38. Kleiger RE, Miller JP, Bigger JT Jr, Moss AJ. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987;59:256-62.
39. Routledge HC, Chowdhary S, Townend JN. Heart rate variability - a therapeutic target? J Clin Pharm Ther 2002;27:85-92.
40. Nolan J, Batin PD, Andrews R, et al. Prospective study of heart rate variability and mortality in chronic heart failure: Results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). Circulation 1998;98:1510-6.
41. Christensen JH, Christensen MS, Dyerberg J, Schmidt EB. Heart rate variability and fatty acid content of blood cell membranes: A dose-response study with n-3 fatty acids. Am J Clin Nutr 1999;70:331-7.
42. Christensen JH, Dyerberg J, Schmidt EB. n-3 fatty acids and the risk of sudden cardiac death assessed by 24-hour heart rate variability. Lipids 1999;34(Suppl):S197.
43. Arnal JF, Dinh-Xuan AT, Pueyo M, Darblade R, Rami J. Endothelium-derived nitric oxide and vascular physiology and pathology. Cell Mol Life Sci 1999;55:1078-87.
44. Vanhoutte PM. Endothelium-dependent hyperpolarizations: The history. Pharmacol Res 2004;49:503-8.
45. German JB, Dillard CJ. Saturated fats: What dietary intake? Am J Clin Nutr 2004;80:550-9.
46. Ong PJ, Dean TS, Hayward CS, Della Monica PL, Sanders TA, Collins P. Effect of fat and carbohydrate consumption on endothelial function. Lancet 1999;354:2134.
47. Keogh JB, Grieger JA, Noakes M, Clifton PM. Flow-mediated dilatation is impaired by a high-saturated fat diet but not by a high-carbohydrate diet. Arterioscler Thromb Vasc Biol 2005;25:1274-9.
48. Pelkman CL, Fishell VK, Maddox DH, Pearson TA, Mauger DT, Kris-Etherton PM. Effects of moderate-fat (from monounsaturated fat) and low-fat weight-loss diets on the serum lipid profile in overweight and obese men and women. Am J Clin Nutr 2004;79:204-12.
49. Volek JS, Feinman RD. Carbohydrate restriction improves the features of metabolic syndrome. Metabolic syndrome may be defined by the response to carbohydrate restriction. Nutr Metab 2005;16:31.
50. Yu G, Guang-Yao S, Hui-Juan M, Wen-Jie Z, Yu Z. Effects of long-term high-saturated and unsaturated fatty acid diets on relaxation and contraction of renal arteries in insulin resistant rats Acta Physiologica Sinica 2007;59:363-8.
51. Deng G, Long Y, Yu YR, Li MR. Adiponectin directly improves endothelial dysfunction in obese rats through the AMPK-eNOS Pathway. Int J Obes (Lond) 2010;34:165-71.